Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Cancer Research

• Publication date

  2008-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-07-4926PMID 18413814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.

  2007cited by this paper
• Identification of neovasculature using nestin in colorectal cancer.

  2007cited by this paper
• Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.

  2007cited by this paper
• Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.

  2007cited by this paper
• Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1

  2006cited by this paper
• Epidermal growth factor receptor (EGFR) signaling in cancer.

  2006cited by this paper
• Topoisomerase IIα in Wilms’ tumour: gene alterations and immunoexpression

  2006cited by this paper
• Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.

  2006cited by this paper
• The Adenomatous Polyposis Coli Tumor Suppressor Gene Regulates Expression of Cyclooxygenase-2 by a Mechanism That Involves Retinoic Acid*

  2006cited by this paper
• Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.

  2006cited by this paper
• Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci.

  2006cited by this paper
• Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane‐treated A/J mice

  2006cited by this paper
• Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.

  2005cited by this paper
• Analysis of the epidermal growth factor receptor specific transcriptome: Effect of receptor expression level and an activating mutation

  2005cited by this paper
• Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth.

  2005cited by this paper
• Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.

  2005cited by this paper
• Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling Pathway

  2004cited by this paper
• Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis

  2004cited by this paper
• Epidermal growth factor receptor in tumor angiogenesis.

  2004cited by this paper
• Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib (‘Iressa’, ZD1839)

  2004cited by this paper
• Subepithelial Myofibroblasts Express Cyclooxygenase-2 in Colorectal Tubular Adenomas

  2004cited by this paper
• Gene mutations and altered gene expression in azoxymethane‐induced colon carcinogenesis in rodents

  2004cited by this paper
• Pathology of mouse models of intestinal cancer: consensus report and recommendations.

  2003cited by this paper
• Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA

  2003cited by this paper
• Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

  2003cited by this paper
• Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.

  2002cited by this paper
• Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

  2002cited by this paper
• Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice.

  2002cited by this paper
• Molecular interpretation of ERK signal duration by immediate early gene products

  2002cited by this paper
• /-Catenin Mediates the Interaction of the Cadherin-Catenin Complex with Epidermal Growth Factor Receptor

  2002cited by this paper
• Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis

  2002cited by this paper
• ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

  2002cited by this paper
• Elevated protein expression of cyclin D1 and Fra‐1 but decreased expression of c‐Myc in human colorectal adenocarcinomas overexpressing β‐catenin

  2002cited by this paper
• Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer

  2002cited by this paper
• Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

  2001cited by this paper
• CCAAT/enhancer binding protein-β is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling

  2001cited by this paper
• The Induction of Cyclooxygenase-2 mRNA in Macrophages Is Biphasic and Requires both CCAAT Enhancer-binding protein β (C/EBPβ) and C/EBPδ Transcription Factors*

  2001cited by this paper
• A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

  2001cited by this paper
• The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta ) and C/EBP delta transcription factors.

  2001cited by this paper
• Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer.

  2000cited by this paper
• Localization of cyclooxygenase-2 in human sporadic colorectal adenomas.

  2000cited by this paper
• Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.

  2000cited by this paper
• Regulation of Cyclooxygenase-2 and Periostin by Wnt-3 in Mouse Mammary Epithelial Cells*

  2000cited by this paper
• Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells*

  2000cited by this paper
• Increased expression of the transcription factors CCAAT‐enhancer binding protein‐B (C/EBB) and C/EBPζ (CHOP) correlate with invasiveness of human colorectal cancer

  2000cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• Primer3 on the WWW for general users and for biologist programmers.

  2000cited by this paper
• β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

  1999cited by this paper
• Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets

  1999cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• Bioinformatics Methods and Protocols

  1999cited by this paper
• Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells

  1998cited by this paper
• Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.

  1997cited by this paper
• Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1

  1997cited by this paper
• Cell proliferation kinetics are abnormal in transitional mucosa adjacent to colorectal carcinoma

  1996cited by this paper
• The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract.

  1996cited by this paper
• Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.

  1995cited by this paper
• Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*)

  1995cited by this paper
• The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.

  1994cited by this paper
• Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor

  1994cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.

  1993cited by this paper
• Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

  1991cited by this paper
• Insulin and epidermal growth factor. Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake.

  1975cited by this paper

• CEBPB emerges as a key regulatory factor in human cancers through diverse molecular mechanisms and clinical implications

  2025cites this paper
• Design and synthesis of peptide-drug conjugates to double target EGFR

  2023cites this paper
• Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies

  2022cites this paper
• Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid

  2020influential citation
• Chemopreventive efficacy zingerone (4‐[4‐hydroxy‐3‐methylphenyl] butan‐2‐one) in experimental colon carcinogenesis in Wistar rats

  2019cites this paper
• Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides

  2018cites this paper
• Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells.

  2017cites this paper
• Epidermal growth factor receptor-targeted therapy in colorectal cancer.

  2016cites this paper
• ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer

  2016cites this paper
• The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer

  2015cites this paper
• Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention.

  2015cites this paper
• EGFR Overexpressed in Colonic Neoplasia Can be Detected on Wide-Field Endoscopic Imaging

  2015cites this paper
• A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum

  2015cites this paper
• The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer

  2014cites this paper
• Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects

  2014cites this paper
• Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells.

  2014cites this paper
• SERS-based detection of biomolecules

  2014cites this paper
• Suppressive effect of RAS inhibitor manumycin A on aberrant crypt foci formation in the azoxymethane‐induced rat colorectal carcinogenesis model

  2013cites this paper
• TNF-α and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: role of LPA-mediated transactivation of upregulated EGFR

  2013cites this paper
• Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.

  2013cites this paper
• Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domain.

  2013cites this paper
• Cancer Stem Cells Biomarkers in Gastric Carcinogenesis

  2013cites this paper
• Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer

  2013cites this paper
• Phthalocyanine-peptide conjugates for epidermal growth factor receptor targeting.

  2012cites this paper
• TNF-α induces upregulation of EGFR expression and signaling in human colonic myofibroblasts.

  2012cites this paper
• Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro.

  2012cites this paper
• Dual Inhibition of VEGFR and EGFR is an Effective Chemopreventive Strategy in the Mouse 4-NQO Model of Oral Carcinogenesis

  2012cites this paper
• Epidermal growth factor receptor (EGFR) gene copy number in colorectal adenoma-carcinoma progression.

  2012cites this paper
• The neurotensin receptor‐1 promotes tumor development in a sporadic but not an inflammation‐associated mouse model of colon cancer

  2012cites this paper
• Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts.

  2012influential citation
• Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia

  2011cites this paper
• Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin

  2011cites this paper
• Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

  2011cites this paper
• Chrysophanic acid blocks proliferation of colon cancer cells by inhibiting EGFR/mTOR pathway

  2011cites this paper
• The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer

  2011cites this paper
• EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators

  2011influential citation
• Mutations in K-ras and Epidermal Growth Factor Receptor Expression in Korean Patients With Stages III and IV Colorectal Cancer

  2011cites this paper
• Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor.

  2011cites this paper
• Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.

  2011cites this paper
• Signaling and Regulation EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet – Promoted Murine Colon Cancer : Role of G 1 Regulators

  2011influential citation
• Effect of Dietary Fish Protein and Fish Oil on Azoxymethane-induced Aberrant Crypt Foci in A/J Mice

  2011cites this paper
• Colorectal Neoplasia Phase IIa Clinical Trial of Curcumin for the Prevention of Updated

  2011cites this paper
• IV Colorectal Cancer Mutations in Kras and Epidermal Growth Factor Receptor Expression in Korean Patients With Stages

  2011cites this paper
• Inhibition of Vascular Endothelial Growth Factor eptor and Epidermal Growth Factor Receptor is ffective Chemopreventive Strategy in the Mouse Pr R QO Model of Oral

  2010cites this paper
• Ursodeoxycholic acid and chemoprevention of colorectal cancer.

  2010cites this paper
• Dual Inhibition of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor is an Effective Chemopreventive Strategy in the Mouse 4-NQO Model of Oral Carcinogenesis

  2010cites this paper
• Relation of the Expression of Cyclooxygenase-2 in Colorectal Adenomas and Adenocarcinomas to Angiogenesis and Prognosis

  2010cites this paper
• Correlation of Epidermal Growth Factor Receptor With Morphological Features of Colorectal Advanced Adenomas: A Pilot Correlative Case Series

  2010cites this paper
• Inflammation and Liver Cancer

  2009cites this paper
• Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2

  2009cites this paper
• Mucin‐depleted foci show strong activation of inflammatory markers in 1,2‐dimethylhydrazine‐induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate

  2009influential citation
• Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway

  2009cites this paper
• Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail

  2008cites this paper
• Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat

  2008cites this paper
• Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.

  2008cites this paper
• Effects of neonatal administration of diethylstilbestrol on aberrant crypt foci induced by 7,12-dimethylbenz[alpha] anthracene in rats.

  2008cites this paper